DNTH vs LI · rev $6.2M vs P/E 24, rev $16.06B
Dianthus Therapeutics Inc. (DNTH) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
DNTH currently screens at market cap $4.40B. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the DNTH and LI stock pages for the full models.
Not investment advice.